Literature DB >> 22269035

Atrial electrical and structural remodeling associated with longstanding pulmonary hypertension and right ventricular hypertrophy in humans.

Caroline Medi1, Jonathan M Kalman, Liang-Han Ling, Andrew W Teh, Geoffrey Lee, Geraldine Lee, Steven J Spence, David M Kaye, Peter M Kistler.   

Abstract

INTRODUCTION: Pulmonary hypertension (PH) is common to a range of cardiopulmonary conditions and is associated with atrial arrhythmias. However, little is known of the isolated atrial effects of PH and right atrial dilatation (RA) in humans. To avoid the confounding effects of PH-associated disease states, we performed detailed electrophysiological (EP) and electroanatomic (EA) mapping of the RA in patients with idiopathic PH. METHODS AND
RESULTS: Eight PH patients (mean pulmonary arterial [PA] pressure 39.0 ± 15.8 mmHg) and 16 age-matched controls (mean PA pressure 11.5 ± 4.1 mmHg, P < 0.0001) were studied. Corrected sinus node recovery times (cSNRT), atrial effective refractory periods (ERPs), conduction delay at the crista terminalis (CT), and inducibility of atrial fibrillation (AF) were evaluated. EA mapping (pacing cycle length 600 and 300 milliseconds) was performed to determine RA global and regional voltage, conduction velocities, atrial activation times, fractionated electrograms and double potentials. Patients with PH demonstrated a prolongation in cSNRT without significant change in atrial ERP and an increase in AF inducibility. PH was associated with lower tissue voltage (1.8 ± 0.4 mV in PH vs 2.2 ± 0.4 mV in controls, P = 0.02), increased low voltage areas (13.7 ± 8.2% in PH vs 6.2 ± 3.7% in controls, P < 0.01) and the presence of electrically silent areas. Conduction velocities were slower (global 67.3 ± 5.6 cm/s vs 92.8 ± 4.0 cm/s, P < 0.001) and fractionated electrograms and double potentials were more prevalent (14.7 ± 4.4% vs 6.3 ± 4.1, P < 0.01) in PH compared with controls, respectively.
CONCLUSION: Idiopathic PH is associated with RA remodeling characterized by: generalized conduction slowing with marked regional abnormalities; reduced tissue voltage; and regions of electrical silence. These changes provide important insights into the isolated effects of PH fundamental to a range of clinical conditions associated with AF.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22269035     DOI: 10.1111/j.1540-8167.2011.02255.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  23 in total

Review 1.  Management of arrhythmias in pulmonary hypertension.

Authors:  S Ashwin Reddy; Sarah L Nethercott; Bharat V Khialani; Andrew A Grace; Claire A Martin
Journal:  J Interv Card Electrophysiol       Date:  2021-04-05       Impact factor: 1.900

2.  The Role of Pulmonary Artery Wedge Pressure on the Incidence of Atrial Fibrillation and Atrial Tachycardias in Patients With Isolated Pre-capillary Pulmonary Hypertension.

Authors:  M Dusik; Z Fingrova; D Ambroz; P Jansa; A Linhart; S Havranek
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

3.  The spectrum and prevalence of arrhythmia in different clinical pulmonary hypertension groups in Chinese population.

Authors:  Lin Xue; Yi-Cheng Yang; Qing Zhao; Zhi-Hui Zhao; Qi-Xian Zeng; Tao Yang; Qin Luo; Bing-Yang Liu; Xiu-Ping Ma; Zhi-Hong Liu; Chang-Ming Xiong
Journal:  Clin Cardiol       Date:  2022-03-07       Impact factor: 3.287

4.  The effects of radio-frequency ablation on blood pressure control in patients with atrial fibrillation and hypertension.

Authors:  Alexies Ramirez; Christina F Pacchia; Natalie A Sanders; Stephen L Wasmund; Mohamed H Hamdan
Journal:  J Interv Card Electrophysiol       Date:  2012-08-11       Impact factor: 1.900

5.  Atrial Arrhythmias in Pulmonary Hypertension: Pathogenesis, Prognosis and Management.

Authors:  Brett Wanamaker; Thomas Cascino; Vallerie McLaughlin; Hakan Oral; Rakesh Latchamsetty; Konstantinos C Siontis
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-03

6.  The correlation of pulmonary arterial hypertension with late recurrence of paroxysmal atrial fibrillation after catheter ablation.

Authors:  Yan-Qun Zhang; Fei-Long Zhang; Wei-Wei Wang; Xue-Hai Chen; Jian-Hua Chen; Liang-Long Chen
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

7.  The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.

Authors:  Roddy Hiram; Feng Xiong; Patrice Naud; Jiening Xiao; Martin Sirois; Jean-François Tanguay; Jean-Claude Tardif; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

8.  Acute effects of inhaled iloprost on intracardiac conduction in patients with pulmonary arterial hypertension.

Authors:  Mustafa Yildiz; Serkan Kahraman; Ozgur Surgit; Hicaz Zencirkiran Agus; Begum Uygur; Ali R Demir; Mehmet E Kalkan; Kadriye Memic Sancar; Ender Oner; İsmail Gurbak; Ali K Kalkan
Journal:  Herz       Date:  2021-06-10       Impact factor: 1.443

9.  Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.

Authors:  Changrong Nie; Changsheng Zhu; Minghu Xiao; Zhengyang Lu; Qiulan Yang; Yanhai Meng; Rong Wu; Shuiyun Wang
Journal:  Front Cardiovasc Med       Date:  2021-07-07

10.  Radiofrequency Catheter Ablation of Supraventricular Tachycardia in Patients With Pulmonary Hypertension: Feasibility and Long-Term Outcome.

Authors:  Bin Zhou; Yong-Jian Zhu; Zheng-Qin Zhai; Si-Xian Weng; Ya-Zhe Ma; Feng-Yuan Yu; Ying-Jie Qi; Yi-Zhou Jiang; Xin Gao; Xi-Qi Xu; Xin Jiang; Zhi-Cheng Jing; Min Tang
Journal:  Front Physiol       Date:  2021-06-18       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.